Live feed/
Filings
/
SCHEDULE
/
0000902664-25-001335
Stake: 19.99%
Shares: 11,914,961
CUSIP: 00032Q104
Class: Common stock, par value $0.0001 per share
Item 4 — Purpose of Transaction
On February 28, 2025, the Issuer obtained the Required Stockholder Approval for the 2024 PIPE Financing. The 2024 PIPE Financing closed on March 4, 2025, pursuant to which Avoro Life Sciences acquired Pre-Funded Warrants to purchase 6,666,400 shares of Common Stock and Avoro Ventures Fund acquired 3,999,673 shares of Common Stock.
Cross-References
Insider Activity (last 365d)
1 transaction
0 buys · 1 sales · 0 awards/exercises
Issuer Cluster
6 13D/G filings on this issuer
5 other filings besides this one
Filer Track Record
1 filings by this filer
0 other filings in the data moat
Short Interest · settle 2026-03-31
DTC 3.88
693,909 shares short · -3.9% vs prior
Form 4 Insider Transactions · last 365d
| Date | Insider | Role | Type | Shares | Price | Value |
|---|
| 2026-04-13 |
BALL BRYAN |
officer |
Sale |
26,389 |
$3.46 |
$91K |
Other 13D/G Filings on Aadi Bioscience, Inc.
| Filed | Form | Filer | Stake | Shares | |
|---|
| 2025-03-06 |
SCHEDULE |
Desai Neil |
4.90% |
2,272,941 |
view → |
| 2025-02-24 |
SCHEDULE |
BML Investment Partners, L.P. |
9.90% |
2,435,000 |
view → |
| 2025-02-04 |
SCHEDULE |
BML Investment Partners, L.P. |
9.90% |
2,435,000 |
view → |
| 2025-01-24 |
SCHEDULE |
ACUTA CAPITAL PARTNERS, LLC |
7.80% |
1,921,297 |
view → |
| 2018-07-02 |
SC |
ORBIMED ADVISORS LLC |
— |
— |
view → |
Want this depth on every filing the moment it hits SEC EDGAR?
Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.
Request a pilot →